Drug delivery device and electronic unit
The drive unit with a mechanical locking mechanism and electronic authentication in drug delivery devices addresses ease of use and patient safety by requiring correct attachment and adherence to prescription schedules, enhancing safety and cost-effectiveness.
Patent Information
- Application Number
- JP2024526563
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-03
- Filing Date
- 2022-11-01
- Publication Date
- 2024-11-13
AI Technical Summary
Existing drug delivery devices, particularly for chronic disease management, face challenges in ensuring patient safety and ease of use, especially for physically frail individuals with impaired vision, while providing variable dose settings and preventing misuse.
A drive unit for drug delivery devices with a mechanical locking mechanism that requires electronic authentication through an auxiliary device for unlocking, ensuring correct attachment and adherence to prescription schedules, and preventing unauthorized use.
Enhances patient safety by ensuring correct drug administration and adherence to prescribed doses, while maintaining a cost-effective design without electromechanically implemented actuators.
Smart Images

Figure 2024542087000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a drive unit for a drug delivery device, in particular a drive unit for a handheld injection device. The present disclosure further relates to a drug delivery system, a drive unit and an auxiliary device for use with the drug delivery device. [Background technology]
[0002] Drug delivery devices for setting and dispensing single or multiple doses of liquid medicaments are per se well known in the art. In general, such devices have substantially the same purpose as a conventional syringe.
[0003] Drug delivery devices, e.g., injection devices and needle-based injection system (NIS) devices such as pen-type injectors, must meet multiple user-specific requirements. For example, for patients suffering from chronic diseases such as diabetes, the patient may be physically frail and have poor eyesight. Therefore, a suitable drug delivery device, especially intended for home medicines, must be of robust construction and must be easy to use. Furthermore, the operation and general handling of the device and its parts must be straightforward and easily understandable. Such an injection device should provide for the setting and subsequent dispensing of variable-sized drug doses. Furthermore, the dose setting as well as the dose dispensing procedure must be easy to operate and clear.
[0004] A patient suffering from a particular disease may require a certain amount of medication to be injected via a syringe pen or infused by a pump.
[0005] Some drug delivery or injection devices allow for the selection of variable sized drug doses and inject a preset dose. Some injection devices allow for the setting and dispensing of a fixed dose, where the amount of drug that must be injected according to a predefined prescription schedule is always the same and does not or must not change over time.
[0006] Some injection devices are realized as reusable injection devices, where the drug container, such as a cartridge, can be replaced by the user. Other injection devices are realized as disposable injection devices, where the intention is to discard the entire injection device once the contents, i.e. the drug, have been used up.
[0007] In a reusable injection device, the drug fluid container, i.e. the cartridge, must be replaced when the drug runs out. Here, the drug container, e.g. a glass cartridge filled with the drug fluid, must be replaced. Some primary drug containers, e.g. in the form of a cartridge filled with the drug, are preassembled in a housing part of the injection device, such as a cartridge holder.
[0008] For example, there are further electronic units, also indicated as auxiliary or add-on devices, integrated into such delivery or injection devices or provided as separate devices. Such auxiliary devices provide additional functionality to the all-mechanically realized drug delivery or injection devices. By means of the auxiliary devices, the setting of drug doses and the repetition of dosing or injection can be precisely monitored and recorded over time. The auxiliary devices provide a wide variety of auxiliary functions for the regular use of the drug delivery or injection devices. The auxiliary devices can perform data analysis and further transmission of such data to the healthcare provider. Such data is indicative of the amount of drug administered at a particular time or on a particular date.
[0009] Electronically implemented auxiliary devices, for example detachable and mechanically connectable to the drug delivery device or injection device, can facilitate the handling and operation of such drug delivery devices. Summary of the Invention [Problem to be solved by the invention]
[0010] In view of the above, it is a further object to enhance patient safety, to improve the range of functionality of such auxiliary devices, drug delivery devices for use with such auxiliary devices, and to provide an improved injection system including a drug delivery device and an auxiliary device. [Means for solving the problem]
[0011] In one aspect, the present disclosure relates to a drive unit of a drug delivery device. The drug delivery device is realized as an injection device, for example a hand-held injection device, in particular a pen-type injection device. The drug delivery device, and thus the drive unit, is configured for setting and dispensing a drug dose. The drive unit includes a drive unit housing extending along a longitudinal axis. The drive unit further includes drive unit parts, i.e. mechanical parts, movably arranged in or on the drive unit housing for at least one of setting a dose and dispensing a drug dose.
[0012] The drive device further includes a locking mechanism. The locking mechanism includes a mechanical locking element. The mechanical locking element is transitionable between a release position and a locking position. Thus, the mechanical locking element is transitionable between a release configuration and a locking configuration. The mechanical locking element is configured to mechanically engage with the drive unit part when in the locking position or configuration. When the mechanical locking element is in the locking position, it is operable to inhibit at least one of setting a dose and dispensing a drug dose. When in the locking position or configuration, the mechanical locking element mechanically engages with the mobile drive unit part to block and / or inhibit respective movement thereof.
[0013] The mechanical locking element is exclusively or only transitionable from a locked position to a released position by interaction with an electronically controlled release mechanism of the auxiliary device. The auxiliary device is configured to be attached to the drive unit housing. Typically, the drive unit housing is mechanically engagable with the auxiliary device. The auxiliary device may be removably connectable or removably securable to the drive unit housing. Once properly secured or attached to the drive unit housing, the release mechanism of the auxiliary device is operable to release the mechanical locking mechanism of the drive unit.
[0014] The locking mechanism of the drive unit is in particular realised such that it can only be exclusively transferred to a released or unlocked configuration through interaction with an electronically controlled release mechanism of the auxiliary device.
[0015] In some instances, it is intended that the locking mechanism is in the locked position by default. A release mechanism of the auxiliary device must then be utilized to release the lock on the drive unit. This may require proper and accurate assembly of the auxiliary device to the drive unit housing of the drive unit. A lack of attachment or incorrect installation or attachment of the auxiliary device to the drive unit housing may lead to improper placement or alignment of the release mechanism relative to the locking mechanism. Thus, if the auxiliary device is not properly attached to the drive unit housing, the release mechanism of the auxiliary device will not be able to transition the locking mechanism of the drive unit to the released configuration or position and therefore will not be able to operate as such.
[0016] In this way, correct and proper attachment of the auxiliary device to the drive unit or drive unit housing is a prerequisite for unlocking the drive unit for setting a dose and / or dispensing or injecting a drug dose.
[0017] In some examples, the mechanical locking element of the drive unit of the drug delivery device is directly movable or transferable by the release mechanism of the auxiliary device. In this way, the drive unit of the drug delivery device may be free of an electrically or electronically implemented actuator capable of transferring the mechanical locking element from the locked position to the released position. Such an electromechanically implemented actuator is provided exclusively by the release mechanism of the auxiliary device. This solution is rather cost-effective, since the drive unit of the drug delivery device can be part of a disposable drug delivery device or a disposable injection device, while the auxiliary device is intended for long-term use with multiple drug delivery devices.
[0018] In some examples, the mechanical locking element is only movable or movable by an actuator of the release mechanism of the auxiliary device. In this way, the drive unit of the drug delivery device can be realized without an electromechanically implemented actuator. Thus, the drug delivery device and the drive unit may be free of electromechanically implemented parts, thus enabling a cost-efficient design and realization of the drug delivery device.
[0019] The unlocking of the drive unit of the drug delivery device exclusively by the auxiliary device can be beneficial in many aspects. In one aspect, the unlocking of the drive unit is only possible if the auxiliary device is correctly attached or assembled to the drive unit housing. Thus, the drive unit and the drug delivery device cannot be used without the presence of the auxiliary device and / or without the correct attachment of the auxiliary device.
[0020] In a further aspect, the auxiliary device itself may comprise an electrically or electronically implemented authentication function or arrangement, which may electronically control authorized access to the auxiliary device and thus to the drive unit. Thus, the auxiliary device may be implemented to transition the mechanical locking element of the drive unit to the released position or configuration only if a user attempting to use the drive unit or drug delivery device successfully passes an authentication procedure by the auxiliary device.
[0021] Additionally, the auxiliary device may be programmably controlled to provide a type of automatic locking or unlocking of the drive unit. In some examples, the auxiliary device may be provided with patient-specific data indicating, for example, the amount of medication and / or the time or date that the injection is scheduled for. Because the auxiliary device is configured to unlock the locking mechanism only if user-guided actuation or manipulation of the drive unit coincides with a predetermined prescription or dosing schedule, a user attempting to use the drive unit at any other time to administer an improperly sized dose is effectively prevented from doing so.
[0022] In a further example, the authentication function performed by the auxiliary device may be operable to distinguish between different container units, for example comprising different drug containers or medicaments, where the drive unit may be configured to engage with several different configurations of container units, for example differing amounts, concentrations and types of drugs or medicaments. Each of the container units, which are generally attachable to the drive unit, may be provided with a unique identifier, for example by means of an electrically detectable or visual code or coding feature. Here, the auxiliary device may be operable to read or extract the associated code information in order to obtain respective information regarding the drugs or medicaments provided in the container units.
[0023] The container unit comprising the drug container is visually or electronically encoded by a respective coding feature, implemented for example as a barcode, as a QR code or in the form of an electronically readable code, for example provided by an RFID chip. The auxiliary device and / or an external electronic device operable to communicate with the auxiliary device may be operable to capture and / or read or extract the coding feature of the container unit. Based on the captured coding feature, at least one of the auxiliary device and the external electronic device may evaluate the coding feature. The evaluation of the coding feature may include, for example, a comparison of the coding feature with user-specific information stored in one of the auxiliary device and the external electronic device. If the coding feature matches the user-specific information, for example if it should be determined that the type of drug located in the container unit matches the prescription schedule of a particular user, the locking mechanism should be transitioned to a release configuration to enable and assist administration of the drug dose.
[0024] In other cases, if the type of medication should be determined to be inconsistent with, for example, a particular user's predetermined prescription schedule, the electronic unit, and thus its processor, can be operable to maintain the locking mechanism in a locked configuration to protect the patient from administration of medication inconsistent with the prescription schedule. In this manner, misuse or unintended use of the drive unit can be effectively prevented.
[0025] Authentication for switching the locking mechanism to the released configuration is not limited to detection of the correct medication, but may also include compliance with a predetermined time schedule, for example, if the user attempts to administer the medication at a time that is not consistent with the predetermined prescription schedule, the locking mechanism may remain in the interlock configuration.
[0026] According to a further example, the mechanical locking element is movably disposed within the drive unit housing. The mechanical locking element can be disposed within an opaque portion of the drive unit housing. The mechanical locking element can be concealed by the drive unit housing and disposed in a visually hidden portion of the drive unit housing. Thus, it may not be visible from outside the drive unit or the drive unit housing where the mechanical locking element is actually disposed. Nevertheless, the release mechanism of the auxiliary device is enabled and configured to mechanically interact with the mechanical locking element when the auxiliary device is properly attached, secured or assembled to the drive unit housing.
[0027] Typically, the mechanical locking element is disposed entirely within the drive unit housing. The mechanical locking element does not protrude from or intersect with the drive unit housing. In this way, the mechanical locking element remains completely hidden and covered within the drive unit housing. Such an arrangement is particularly used to prevent unauthorized movement or reconfiguration of the mechanical locking element, i.e., reconfiguring or repositioning the mechanical locking element without the use of an auxiliary device.
[0028] According to a further example, the mechanical locking element is mechanically inaccessible from outside the drive unit housing. The drive unit housing can therefore completely enclose the mechanical locking element. Movement or reconfiguration of the mechanical locking element may then require some other type of interaction between the release mechanism and the mechanical locking element, for example an electrically induced interaction. Such an interaction may be based on magnetic or electrostatic forces that are transferable through the drive unit housing.
[0029] Moving or reconfiguring the mechanical locking elements to transition them from a locked position toward a released position may require the presence of dedicated magnetic or electrostatic forces at specific locations on the exterior surface of the drive unit housing, and these forces are generally difficult to generate without the aid of appropriate auxiliary devices.
[0030] In other examples, the drive unit housing can include a recess or access opening that is in line with the mechanical locking element, so that a dedicated portion, e.g., in the form of a movable pin, of the release mechanism of the auxiliary device can access the mechanical locking element by entering the recess and / or by penetrating or extending through the access opening in the drive unit housing.
[0031] In such instances, it is contemplated that the recesses and / or access openings may include diameters or cross-sections smaller than, or even much smaller than, the diameter or cross-section of a user's finger. Moreover, such recesses or access openings may include cross-sections that are so small that they require a special tool, such as a specialized pin of the assistive device, to successfully enter the recess or access opening.
[0032] In a further example, the recess or access opening aligned with the mechanical locking element comprises a keyed structure, such as a geometric structure of regular or irregular cross-section, that can only accept a complementary shaped pin of the auxiliary device.
[0033] According to a further example, the mechanical locking element includes a body having at least one of a ferromagnetic material and a magnetized material to magnetically interact with the release mechanism, where the release mechanism of the auxiliary device typically comprises an actuator including an electromagnet, the actuator of the auxiliary device configured to generate a magnetic field that interacts with the ferromagnetic material and / or the magnetized material of the mechanical locking element to transition the mechanical locking element from one of the locked position or locking configuration to the released position or unlocked configuration.
[0034] Such magnetic interaction is particularly beneficial in that the mechanical locking elements can be completely enclosed within the drive unit housing.
[0035] According to a further example, the drive unit housing includes a fastening structure configured to releasably engage a complementary fastener of the auxiliary device. The fastening structure is disposed in the drive unit housing or drive unit housing such that when engaged with the complementary fastener of the auxiliary device, the mechanical locking element is aligned with an actuator of the release mechanism of the auxiliary device. Thus, geometric alignment between the actuator of the release mechanism and the mechanical locking element of the locking mechanism is obtained when the fastening structure is properly engaged with the complementary fastener of the auxiliary device.
[0036] Typically, and in a further example, the mechanical locking element is misaligned or misaligned with the actuator of the release mechanism when the fastening structure is mis-engaged or mis-engaged with a complementary fastener of the auxiliary device. With a misaligned or misaligned arrangement of the mechanical locking element and the actuator, the actuator cannot operate to transition the mechanical locking element from the locked position to the unlocked or released position. Thus, the auxiliary device must be properly assembled to or on the drive unit housing of the drive unit in order to unlock the locking mechanism.
[0037] According to a further example, the mechanical locking element is movably fastened to one of the drive unit part and the drive unit housing. The mechanical locking element is configured to engage the other of the drive unit part and the drive unit housing when transitioned from a release position to a locking position. When the mechanical locking element is movably fastened, e.g. to the drive unit housing, it is disengaged from engagement with the drive unit part as long as the mechanical locking element is in the release position or release configuration. When the mechanical locking element is transitioned to the locking position, the mechanical locking element engages with the drive unit part.
[0038] In the locking configuration or blocking position, the mechanical locking element can directly or indirectly mechanically engage the drive unit components and the drive unit housing, thereby preventing or inhibiting movement of the drive unit components relative to the drive unit housing. In effect, when the mechanical locking element is in the locking position, the drive unit components are prevented from moving relative to the drive unit housing. Here, when in the locking configuration, setting a dose or dispensing a dose is effectively prevented by the fixed position of the drive unit components relative to the drive unit housing.
[0039] In other examples, the mechanical locking element is movably fastened to or within the drive unit housing such that, when the mechanical locking element is moved into a locked position or configuration, the mechanical locking element mechanically engages the drive unit component, thereby preventing movement of the drive unit component relative to the drive unit housing.
[0040] When engaged with the drive unit housing and the drive unit part, the mechanical locking element is operable to prevent at least one of longitudinal and rotational movement of the drive unit part relative to the drive unit housing. In a further example, the drive unit part may protrude from the drive unit housing. The drive unit part may form part of the outer casing of the drive unit. Here, when the locking mechanism enters the locking position, it may be operable to lock the drive unit part relative to the second drive unit part, which is at least temporarily movably fixed relative to the drive unit housing. In this way, a kind of indirect mechanical fixation of the drive unit part to the drive unit housing can be obtained by the mechanical locking element.
[0041] In a further example, the drive unit part is rotatable relative to the longitudinal axis for at least one of setting a dose and dispensing a dose. The drive unit part includes a tubular side wall having a toothed structure. The locking element includes a latch that is radially movable, pivotable or deformable to engage with the toothed structure. Typically, the latch includes a corresponding toothed structure for mechanically engaging with the toothed structure of the side wall of the drive unit part. In this way, when the latch engages with the toothed structure of the drive unit part, the drive unit part is prevented from further rotating relative to the longitudinal axis as the axis of rotation.
[0042] Typically, at least one of the latch and the toothed structure includes a protrusion for engaging a complementary shaped recess on the other of the latch and the toothed structure. In some examples, the toothed structure is provided on an outwardly facing sidewall of the tubular drive unit component. The latch is then biased radially inward to engage the toothed structure. In other examples, the toothed structure is provided on an inner surface of a sidewall of the drive unit component. The latch is then typically biased radially outward to engage the toothed structure.
[0043] The interaction between the release mechanism of the auxiliary device and the mechanical locking element is typically implemented such that, for example, the engagement between the latch and the toothed structure is at least temporarily disabled when the electrically controlled release mechanism of the auxiliary device is activated or triggered. In some examples, the drive unit part is realized as a number sleeve, as a rotatable clutch element, or as a drive sleeve of the drive unit configured to rotate relative to the drive unit housing for at least one of setting a dose and dispensing a dose.
[0044] According to further examples, the drive unit part is longitudinally displaceable for at least one of setting a dose and dispensing a dose. The locking mechanism includes a retaining element longitudinally fixed to the drive unit part with respect to the longitudinal axis. The retaining element is radially movable with respect to the longitudinal axis between a retaining position and a release position. In some examples, when in the retaining position, the retaining element protrudes radially outward or radially inward from the drive unit part and can axially or longitudinally engage with a further drive unit part or the drive unit housing.
[0045] This longitudinal engagement can serve to prevent or impede longitudinal movement of the retaining member and thus of the drive unit part relative to the further drive unit part and / or relative to the drive unit housing. Similarly, a rotational movement of the drive unit part relative to the drive unit housing and / or relative to the further drive unit part is additionally or alternatively prevented by the radially protruding retaining element.
[0046] In some examples, two or more retaining elements can be provided, each of which is fixed to the drive unit part with respect to a longitudinal axis and radially movable relative to the drive unit part. In this way, a double, or even triple, thus multiple, longitudinal abutments can be provided between the drive unit part, the retaining element and at least one of the further drive unit part and the drive unit housing, where the further drive unit part is longitudinally and / or non-rotatably fixed to the housing.
[0047] In effect, when the retaining element protrudes radially, for example from a side wall, of the tubular drive unit part, the drive unit part is effectively prevented from moving in the longitudinal direction, and thus along or parallel to the longitudinal axis.
[0048] In a further example, the locking element is movably supported in or on the drive unit part and mechanically engages with the retaining element, where longitudinal movement of the locking element from the locking position to the release position is effective to cause movement of the retaining element from the retaining position to the release position. Furthermore, the mutual mechanical engagement between the drive unit part, the locking element and the retaining element may be such that longitudinal movement of the locking element from the release position to the locking position is effective to cause movement of the retaining element from the release position to the retaining position.
[0049] In this way, the longitudinal movement of the locking element relative to the drive unit part serves to induce a radial movement of the at least one retaining element, whereby the retaining element longitudinally engages with the drive unit housing and at least one of the further drive unit parts longitudinally fixed to the drive unit housing. In this way, a mechanical interlock of the drive unit parts is provided. The radial movement of the retaining element may be operable, directly or indirectly, for example via another drive unit part longitudinally and / or non-rotatably fixed to the drive unit housing, to prevent longitudinal displacement of the drive unit part relative to the drive unit housing and / or to prevent longitudinal sliding between the drive unit part and the drive unit housing.
[0050] In another example, the drive unit part is movable from an initial position to an end position for at least one of setting a dose and dispensing a dose, and when in a locked position, the mechanical locking element is operable to secure the drive unit part in the initial position, where when transitioned or switched to a released position, the mechanical locking element releases the drive unit part and enables or allows movement of the drive unit part to the end position.
[0051] Typically, when the drive unit part is realized as one of a dose dial and a number sleeve movable for setting the dose, a mechanical locking element is configured to lock the device part in an initial position, which may correspond to a so-called zero dose configuration. The drive unit is then locked in the zero dose configuration. Thus, setting of the dose is effectively prevented.
[0052] In other examples, when the drive unit part is realised as a trigger or dose button that can be depressed for dispensing a dose, the mechanical locking element is configured to inhibit and / or prevent the dose dispensing action.
[0053] In yet another example, the drive unit part includes an elongated bore in which a mechanical locking element is slidably disposed or configured, where the mechanical locking element is slidably displaceable relative to the drive unit part between a release position and a locking position. Typically, the mechanical locking element is slidably disposed within the elongated bore between a distal end position and a proximal end position. In the distal end position, the mechanical locking element may be in a release position or a release configuration. In the proximal end position, the mechanical locking element may be in a blocking position. In another example, the release position coincides with the proximal end position and the locking position coincides with the distal end position. Typically, the elongated bore extends parallel to the longitudinal axis.
[0054] The elongated bore may be open towards the proximal end to receive a complementary shaped pin of an electrically controlled release mechanism of the auxiliary device when the auxiliary device is properly attached to the drive unit housing. The diameter or cross-section of the elongated bore typically matches the complementary diameter or cross-section of the pin of the release mechanism of the auxiliary device and is configured to enter the elongated bore when the auxiliary device is properly assembled and attached to the drive unit housing.
[0055] When properly assembled or attached to the drive unit housing, the movable pin of the electrically controlled release mechanism is operable to enter longitudinally into the elongated bore to induce longitudinal sliding displacement of the mechanical locking element within the bore.
[0056] In further examples, the locking element includes an elongated locking bolt. The locking bolt includes a radial recess sized to receive at least a portion of the retaining element. In some examples, the elongated locking bolt includes a radial groove extending around the entire circumference of the locking bolt. Thus, the radial recess includes an annular shape extending around the circumference of the locking bolt. The radial recess can be configured to receive multiple retaining elements.
[0057] When viewed from the longitudinal direction of the elongated locking bolt, the radial recess can include a ramp section. Thus, when viewed from the longitudinal direction, the radial recess can include a kind of V-shaped groove. In this way, when the locking bolt or locking element is displaced longitudinally in the elongated bore, the retaining element is pushed radially when it engages with the ramp section of the radial recess.
[0058] In this way, longitudinal movement of the elongated locking bolt or locking element relative to the elongated bore can be translated into radial movement of the retaining element. In some examples, the retaining element includes a plurality of retaining balls, where the single retaining element can include a spherical or geometric shape. The diameter of the retaining element can be greater than the thickness of the sidewall of the drive unit part. In this way, when the retaining element engages with the oblique or beveled edge of the radial recess of the elongated locking bolt, at least a portion of the retaining element is biased radially outward and tends to protrude radially outward from the sidewall of the drive unit part, thereby bringing the drive unit part into locking engagement with either the drive unit housing or a further drive unit part coupled or secured to the housing.
[0059] According to a further example, the drive unit part comprises a side wall having a through recess in which the retaining element is axially retained and in which the retaining element is radially movable. In this way, the retaining element is prevented from moving longitudinally when it engages with the oblique or beveled edge of the radial recess of the elongated locking bolt. The longitudinal movement of the mechanical locking element relative to the drive unit part is then completely transferred to the radial movement of the retaining element.
[0060] In some examples, the retaining element may include several retaining segments, each of which is fixed longitudinally to the drive unit part or to a side wall of the drive unit part, where each of the retaining segments or retaining elements may be individually movable radially relative to the drive unit part.
[0061] The retaining element is realized as an annular segmented structure capable of supporting radially outward extension against an inherent radially inward restoring force, where the retaining element can be made of an elastic material configured to elastically transition from a retaining position back to a release position in the absence of the effect of a force acting on the elongated locking bolt. Thus, the retaining element or elements can be operable to relax or return to the retaining position, thereby resulting in an automated activation of the locking mechanism.
[0062] According to a further example, the locking mechanism includes a return spring operable to engage with the mechanical locking element and transition the mechanical locking element from the release position to the locking position. The return spring can be configured to move or pivot the mechanical locking element from the release position to the locking position. In this way, the locking mechanism automatically interlocks, for example, in the absence of an electrically controlled release mechanism of the auxiliary device. In other examples, the mechanical locking element itself is provided with a return spring or is realized as an elastically deformable mechanical locking element. Here, at least one of the material and the geometry of the mechanical locking element serves to provide a return force for the mechanical locking element to remain or return to the initial or unbiased shape. Here again, an automated activation of the locking mechanism can rather be provided.
[0063] Typically, the drive unit part is a moving part of the drive unit, either realized as a number sleeve, a dial sleeve, a drive sleeve, a clutch element or any other moving part of the drive mechanism that undergoes rotational and / or longitudinal movement for setting the dose sequence or dispensing the doses.
[0064] According to another aspect, the present disclosure relates to a drug delivery device for setting and dispensing a drug dose. The drug delivery device includes a drive unit as described above. The drug delivery device further includes a container unit configured to accommodate the drug container and further configured to fasten to the drive unit housing. The drive unit is configured to operably engage with the drug container to draw or expel the drug dose from the drug container. In some examples, the drug delivery device includes an injection device. The drug delivery device is realized as a handheld injection device such as an injection pen. In some examples, the drive unit includes a drive unit that is fully mechanically realized, and a user of the drug delivery device must provide an effective dispensing force to draw or expel the drug dose from the drug container.
[0065] In some examples, the drug container includes a cartridge extending along a longitudinal axis and sealed towards a proximal end by a movable stopper, where the drive unit includes an elongated piston rod or plunger for exerting distal pressure on the stopper. In this manner, pressure within the drug container can be increased to expel the drug dose via a distal outlet, typically in fluid communication with an injection needle. In this manner, the piston rod is operable to urge the stopper distally relative to the cartridge or barrel of the drug container to expel the drug dose.
[0066] According to another example, the drug delivery device includes a medicament container arranged in a container unit. Typically, the container unit includes a container holder, for example realized as a cartridge holder sized and configured to accommodate the medicament container. The container unit may include a medicament container realized as a cartridge and may include a cartridge holder sized and shaped to accommodate and fix the cartridge therein. The cartridge holder, and thus the container holder of the container unit, is configured to fasten and fix with the drive unit housing to form or constitute a housing of the drug delivery device. The container unit is removably or non-removably fastened or fixed to the drive unit housing. In a reusable drug delivery device, the drive unit housing and the container unit are removably fixed. In a disposable drug delivery device, the drive unit housing is typically non-removably fixed to the container unit.
[0067] Generally, the drive unit is a component part of the drug delivery device, and therefore all configurations, effects and advantages described above in relation to the drive unit apply equally to the drug delivery device, and vice versa.
[0068] According to another aspect, the present disclosure relates to an auxiliary device for use with the drive unit. The auxiliary device includes a housing configured to be attached to the drive unit. The auxiliary device further includes an electronic unit disposed within the housing. The auxiliary device further includes a release mechanism including an electromagnetic actuator electrically controlled by the electronic unit and operable to transition a mechanical locking element of a locking mechanism of the drive unit to a released position. The electromagnetic actuator may be configured to directly or indirectly engage the mechanical locking element of the locking mechanism of the drive unit. Because the auxiliary device is configured for use with the drive unit, all configurations, effects and advantages discussed above in relation to the drive unit apply equally to the auxiliary device and vice versa.
[0069] In another example, the electromagnetic actuator of the auxiliary device includes one of an electromagnet and a movable pin. The electromagnet is operable to magnetically interact with the mechanical locking element, particularly when the mechanical locking element of the locking mechanism of the drive unit includes at least one of a ferromagnetic material and a magnetized material. In this manner, actuation of the electromagnet generates a magnetic field operable to move or pivot the mechanical locking element from a locked position toward a released position; and vice versa.
[0070] In another example, the electromagnetic actuator includes a moveable pin that mechanically engages a mechanical locking element, the moveable pin being configured to push or drag the mechanical locking element, particularly when slidably disposed in an elongated bore of the drive unit component.
[0071] Typically, the moveable pin is sized and shaped to enter an elongated bore in the drive unit component when the auxiliary device is properly coupled and secured to the drive unit housing.
[0072] In yet another aspect, the present disclosure relates to a drug delivery system. The drug delivery system is realized as an injection system. The drug delivery system includes the above-mentioned auxiliary device, and further includes a drive unit and / or a drug delivery device as described above. To that extent, all configurations, effects and advantages as described above in relation to the auxiliary device, the drive unit, and / or as described above in relation to the drug delivery device apply equally to the drug delivery system, and vice versa.
[0073] In general, the scope of the present disclosure is defined by the content of the claims. The injection device is not limited to a particular embodiment or example, but includes any combination of elements of different embodiments or examples. To that extent, the present disclosure covers any combination of the claims and any technically feasible combination of the features disclosed in relation to the different examples or embodiments.
[0074] It will be further apparent to those skilled in the art that various modifications and variations can be made to the present disclosure without departing from the scope of the present disclosure. Furthermore, it should be noted that any reference numerals used in the appended claims should not be construed as limiting the scope of the present disclosure.
[0075] As used herein, the term "distal" or "distal end" refers to the end of a drug delivery or injection device that faces towards the injection site of a human or animal. The term "proximal" or "proximal end" refers to the opposite end of an injection device that faces away from the injection site of a human or animal.
[0076] The terms "drug" or "medicament" are used interchangeably herein to describe a pharmaceutical formulation containing one or more active pharmaceutical ingredients or their pharma- ceutically acceptable salts or solvates, and optionally a pharma- ceutically acceptable carrier. An active pharmaceutical ingredient ("API"), in its broadest sense, is a chemical structure that has a biological effect on humans or animals. In pharmacology, drugs or medicines are used to treat, cure, prevent, or diagnose diseases or otherwise improve physical or mental well-being. Drugs or medicines can be used for a limited duration or periodically for chronic disorders.
[0077] As described below, a drug or agent may include at least one API or a combination thereof in various types of formulations for the treatment of one or more diseases. Examples of APIs may include small molecules with molecular weights of 500 Da or less, polypeptides, peptides, and proteins (e.g., hormones, growth factors, antibodies, antibody fragments, and enzymes), carbohydrates and polysaccharides, as well as nucleic acids, double-stranded or single-stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), ribozymes, genes, and oligonucleotides. Nucleic acids may be incorporated into molecular delivery systems such as vectors, plasmids, or liposomes. Mixtures of one or more drugs are also contemplated.
[0078] The drug or agent can be contained in a primary package or "drug container" adapted for use in a drug delivery device. The drug container can be, for example, a cartridge, syringe, reservoir, or other rigid or flexible vessel configured to provide a chamber suitable for storage (e.g., short-term or long-term storage) of one or more drugs. For example, in some cases, the chamber can be designed to store the drug for at least one day (e.g., from one day to at least 30 days). In some cases, the chamber can be designed to store the drug for about one month to about two years. Storage can be at room temperature (e.g., about 20°C) or at refrigerated temperatures (e.g., from about -4°C to about 4°C). In some cases, the drug container can be or include a dual-chamber cartridge configured to separately store two or more components of a pharmaceutical formulation to be administered (e.g., an API and a diluent, or two different drugs), one in each chamber. In such cases, the two chambers of the dual-chamber cartridge can be configured to allow mixing between the two or more components before and / or during administration to the human or animal body. For example, the two chambers can be configured to be in fluid communication with each other (e.g., via a conduit between the two chambers) and to optionally allow mixing of the two components by a user prior to administration. Alternatively or additionally, the two chambers can be configured to allow mixing upon administration of the components to the human or animal body.
[0079] The drugs or agents contained in the drug delivery devices described herein can be used for the treatment and / or prevention of many different types of medical disorders. Examples of disorders include, for example, diabetes or complications associated with diabetes, such as diabetic retinopathy, thromboembolic disorders, such as deep vein thromboembolism or pulmonary thromboembolism. Further examples of disorders are acute coronary syndromes (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and / or rheumatoid arthritis. Examples of APIs and drugs are those found in handbooks such as Rote Liste 2014 (e.g., but not limited to, Main Groups 12 (antidiabetic agents) or 86 (oncology agents)) and the Merck Index, 15th edition.
[0080] Examples of APIs for the treatment and / or prevention of type 1 or type 2 diabetes or complications associated with type 1 or type 2 diabetes include insulin, e.g., human insulin, or a human insulin analog or derivative, glucagon-like peptide (GLP-1), a GLP-1 analog or GLP-1 receptor agonist, analog or derivative thereof, a dipeptidyl peptidase-4 (DPP4) inhibitor, or a pharma-ceutically acceptable salt or solvate thereof, or any mixture thereof. As used herein, the terms "analog" and "derivative" refer to a polypeptide having a molecular structure that is formally derivable from the structure of a naturally occurring peptide, e.g., the structure of human insulin, by deletion and / or replacement of at least one amino acid residue present in the naturally occurring peptide and / or by addition of at least one amino acid residue. The added and / or replaced amino acid residues can be either codable amino acid residues or other naturally occurring residues or purely synthetic amino acid residues. Insulin analogs are also referred to as "insulin receptor ligands". In particular, the term "derivative" refers to a polypeptide having a molecular structure formally derivable from the structure of a naturally occurring peptide, for example the molecular structure of human insulin in which one or more organic substituents (e.g., fatty acids) are attached to one or more of the amino acids. Optionally, one or more amino acids present in the naturally occurring peptide are deleted and / or replaced by other amino acids, including non-codeable amino acids, or amino acids, including non-codeable ones, are added to the naturally occurring peptide.
[0081] Examples of insulin analogues are Gly(A21), Arg(B31), Arg(B32) human insulin (insulin glargine); Lys(B3), Glu(B29) human insulin (insulin glulisine); Lys(B28), Pro(B29) human insulin (insulin lispro); Asp(B28) human insulin (insulin aspart); human insulin in which the proline in position B28 may be replaced by Asp, Lys, Leu, Val or Ala and in which the Lys in position B29 may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
[0082] Examples of insulin derivatives are e.g. B29-N-myristoyl-des(B30) human insulin, Lys(B29)(N-tetradecanoyl)-des(B30) human insulin (insulin detemir, Levemir®); B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin. ; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-gamma-glutamyl)-des(B30) human insulin, B29-N-omega-carboxypentadecanoyl-gamma-L-glutamyl-des(B30) human insulin (insulin degludec, Tresiba®); B29-N-(N-lithocholyl-gamma-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
[0083] Examples of GLP-1, GLP-1 analogs and GLP-1 receptor agonists are, for example, lixisenatide (Lyxumia®), exenatide (exendin-4, Byetta®, Bydureon®, a 39 amino acid peptide produced by the salivary glands of the flathead monster), liraglutide (Victoza®), semaglutide, taspoglutide, albiglutide (Syncria®), dulaglutide (Trulicity®), rExendin-4, CJC-1134-PC, PB-1023, TTP-054, langrenatide / HM-11260C (efpegrenatide). , HM-15211, CM-3, GLP-1 Erigen, ORMD-0901, NN-9423, NN-9709, NN-9924, NN-9926, NN-9927, Nodexene, Viador-GLP-1, CVX-096, ZYOG-1, ZYD-1, GSK-2374697, DA-3091, MAR-701, MAR709, ZP-2929, ZP-3022, ZP -DI-70, TT-401 (Pegapamodtide), BHM-034, MOD-6030, CAM-2036, DA-15864, ARI-2651, ARI-2255, Tirzepatide (LY3298176), Bamadutide (SAR425899), Exenatide-XTEN and Glucagon-Xten.
[0084] Examples of oligonucleotides are, for example, the cholesterol-lowering antisense therapeutic mipomersen sodium (Kynamro®) for the treatment of familial hypercholesterolemia, or RG012 for the treatment of Alport Syndrome.
[0085] Examples of DPP4 inhibitors are linagliptin, vidagliptin, sitagliptin, denagliptin, saxagliptin, berberine.
[0086] Examples of hormones include pituitary or hypothalamic hormones or regulatory active peptides and their antagonists, such as gonadotropins (follitropin, lutropin, chorion gonadotropin, menotropin), somatropine (somatropin), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin, and goserelin.
[0087] Examples of polysaccharides include glycosaminoglycans, hyaluronic acid, heparin, low molecular weight heparin or very low molecular weight heparin or their derivatives, or sulfated polysaccharides, such as the above-mentioned polysaccharides in polysulfated form, and / or their pharmaceutically acceptable salts.An example of a pharmaceutically acceptable salt of polysulfated low molecular weight heparin is enoxaparin sodium.An example of a hyaluronic acid derivative is Hylan G-F20 (Synvisc®), sodium hyaluronate.
[0088] The term "antibody" as used herein refers to an immunoglobulin molecule or an antigen-binding portion thereof. Examples of antigen-binding portions of an immunoglobulin molecule include F(ab) and F(ab')2 fragments that retain the ability to bind to an antigen. An antibody can be a polyclonal antibody, a monoclonal antibody, a recombinant antibody, a chimeric antibody, a deimmunized or humanized antibody, a fully human antibody, a non-human (e.g., murine) antibody, or a single chain antibody. In some embodiments, an antibody has effector function and is capable of fixing complement. In some embodiments, an antibody has reduced or no binding ability to Fc receptors. For example, an antibody can be an isotype or subtype, an antibody fragment, or a mutant that does not support binding to Fc receptors, e.g., with a mutation or deletion of the Fc receptor binding region. The term antibody also includes antigen-binding molecules based on tetravalent bispecific tandem immunoglobulins (TBTIs) and / or dual variable region antibody-like binding proteins (CODVs) with crossover binding region orientation.
[0089] The term "fragment" or "antibody fragment" refers to a polypeptide (e.g., antibody heavy and / or light chain polypeptide) derived from an antibody polypeptide molecule that does not include the full-length antibody polypeptide but includes at least a portion of the full-length antibody polypeptide that is still capable of binding to an antigen. An antibody fragment can include truncated portions of a full-length antibody polypeptide, but the term is not limited to such truncated fragments. Antibody fragments useful in the present invention include, for example, Fab fragments, F(ab')2 fragments, scFv (single-chain Fv) fragments, linear antibodies, monospecific or multispecific antibody fragments, such as bispecific, trispecific, tetraspecific and multispecific antibodies (e.g., diabodies, triabodies, tetrabodies), monovalent or multivalent antibody fragments, such as bivalent, trivalent, tetravalent and multivalent antibodies, minibodies, chelating recombinant antibodies, tribodies or bibodies, intrabodies, nanobodies, small modular immunopharmaceuticals (SMIPs), binding domain immunoglobulin fusion proteins, camelized antibodies, and VHH-containing antibodies. Additional examples of antigen-binding antibody fragments are known in the art.
[0090] The term "complementarity determining region" or "CDR" refers to short polypeptide sequences in the variable regions of both heavy and light chain polypeptides that are primarily responsible for mediating specific antigen recognition. The term "framework region" refers to amino acid sequences in the variable regions of both heavy and light chain polypeptides that are not CDR sequences and are primarily responsible for maintaining the proper arrangement of CDR sequences to allow antigen binding. Although framework regions themselves typically do not directly participate in antigen binding, as is known in the art, certain residues in the framework regions of a particular antibody may be directly involved in antigen binding or may affect the ability of one or more amino acids in the CDR to interact with an antigen.
[0091] Exemplary antibodies are anti-PCSK-9 mAbs (e.g., alirocumab), anti-IL-6 mAbs (e.g., sarilumab), and anti-IL-4 mAbs (e.g., dupilumab).
[0092] Pharmaceutically acceptable salts of any of the APIs described herein are contemplated for use in the drug or medicament in the drug delivery device. Pharmaceutically acceptable salts include, for example, acid addition salts and base salts.
[0093] Those skilled in the art will understand that modifications (addition and / or removal) of the various components of the APIs, formulations, devices, methods, systems, and embodiments described herein may be made without departing from the full scope and spirit of the present disclosure, which encompasses such modifications and all equivalents thereof.
[0094] In the following, a number of examples of a drug delivery device configured to interact with an auxiliary device, a drug delivery device, an auxiliary device and a drive unit of a drug delivery system are illustrated and described in more detail by referring to the drawings: [Brief description of the drawings]
[0095] [Figure 1] FIG. 1 shows a schematic diagram of an example of a drug delivery device realized as a hand-held pen-type injector. [Diagram 2] FIG. 2 is an enlarged longitudinal sectional view of a drive unit of the drug delivery device according to FIG. 1; [Diagram 3] FIG. 13 is a cross-sectional view of a mechanical locking element in a locking position. [Figure 4] FIG. 13 shows the mechanical locking element in the released position. [Diagram 5] FIG. 2 shows a schematic perspective view of an auxiliary device before it is attached to the drive unit housing. [Figure 6] FIG. 13 shows details of a fastening mechanism for fastening and securing the receptacle unit to the drive unit, the fastening mechanism being in an interlocking configuration. [Figure 7]FIG. 7 shows the fastening mechanism of FIG. 6 in a released configuration. [Figure 8] FIG. 1 is a block diagram of a drug delivery system. [Figure 9] FIG. 2 shows a schematic diagram of another drive unit of another drug delivery device; [Figure 10] FIG. 10 is an enlarged cross-sectional view of the drive unit of the drug delivery device of FIG. 9, with the locking mechanism in a locking position or configuration. [Figure 11] FIG. 10 is a diagram of the locking mechanism of FIG. 9 in a released position or configuration. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0096] 1 and 2 show an exemplary embodiment of a drug delivery device 1 in cross-sectional view. The drug delivery device 1 is a variable dose device in which different doses of the drug to be dispensed are set or dialed in, respectively, by the user. The drug delivery device is a dial expansion pen.
[0097] 1 also shows a coordinate system used herein to specify the location of members or elements or features. The distal direction D and the proximal direction P are parallel to the longitudinal axis A. The longitudinal axis A is the main axis of extension of the device 1. The radial direction R is perpendicular to and intersects the longitudinal axis A. The tangential direction, also called the circumferential direction, is perpendicular to the radial direction R and the longitudinal axis A.
[0098] The drug delivery device 1 includes a drive unit 3 having a setting mechanism and a dispensing mechanism. The setting mechanism is configured to set a drug dose and the dispensing mechanism is configured to dispense a drug dose. The functioning principle of each mechanism is further explained below.
[0099] The drive unit 3 comprises an inner body 10 and a housing element 11, hereinafter also referred to as the outer body 11. The inner body 10 and the outer body 11 are fixedly connected to each other, i.e. they cannot rotate or move axially relative to each other. The inner body 10 and the outer body 11 can form or constitute a drive unit housing 9. The outer body 11 forms the outer surface of the drug delivery device 1 that can be touched or gripped by a user. The drive unit 3, and thus the drive unit housing 9, comprises a distal end 4 configured to couple with a proximal end of the receptacle unit 2. The drive unit 3 further comprises a proximal end 5 equipped with a dosing button 13. The dosing button 13 can thus form or constitute the proximal end 5 of the drive unit housing 9.
[0100] The drug delivery device 1 further comprises a protective cap 14 and a user interface member 13 in the form of a knob 13. The knob 13 is a dose setting member configured to be operated by a user to set a drug dose and at the same time a dose dispensing member configured to be operated by a user to dispense a drug dose.
[0101] The drug reservoir unit 2, also referred to as container unit 2, comprises a reservoir 16, and a reservoir holder 15 is received in a cap 14. The reservoir 16 is filled with a drug or medicament. The reservoir 16 is sealed in a proximal direction P by a stopper 17.
[0102] The reservoir units 2 are each operatively coupled or connected to a drive unit 3. The drive unit 3 is configured to effect a dispensing process for dispensing a drug dose by acting on the drug reservoir 16. To dispense a drug dose, the stopper 17 is pushed in a distal direction D by a plunger rod 29 of the drive unit 3. When the injection needle 18 is coupled to the drug reservoir, a dose of the drug is injected into the biological tissue.
[0103] The coupling between the drive unit 3 and the reservoir unit 2 is realized by coupling the inner body 10 to the reservoir holder 15 via a coupling interface, which may be a snap coupling or a screw coupling. The coupling is preferably reversible. For example, the container unit 2 is axially and non-rotatably fixed to the inner body 10 by the coupling.
[0104] The drive unit 3 further includes a number sleeve 26 and a dial sleeve 27 that are fixedly coupled to each other (e.g., cannot rotate or move axially relative to each other). The dial sleeve 27 may include an internal thread that engages with an external thread on the inner body 10. The number sleeve 26 has numbers displayed on its outer surface. The numbers are visible to a user through a window 12. The window 12 may include a lens. The window 12 is formed in the outer body 11. The numbers visible in the window 12 indicate to the user the set / dialed dose. The threaded coupling between the dial sleeve 27 and the inner body 10 causes the dial sleeve 27 and the number sleeve 26 to move in a helical path in a proximal direction relative to the bodies 10, 11 during setting of a drug dose and dispensing of a drug dose, as further described below.
[0105] The drive unit 3 further includes a drive sleeve. The drive sleeve includes a distal drive sleeve 20, a proximal drive sleeve 21, and a drive sleeve coupler 22 that couples the distal drive sleeve 20 to the proximal drive sleeve 21. For setting a drug dose and dispensing a drug dose, the distal drive sleeve 20 and the proximal drive sleeve 21 are fixedly coupled to each other via the drive sleeve coupler 22 such that these elements cannot rotate or move axially relative to each other. The distal drive sleeve 20 may include an internal thread that engages with the external thread of the plunger rod 29. The external thread of the distal drive sleeve 20 may engage with the internal thread of a final dose nut 30, the function of which will be further described below.
[0106] Additionally, the drive unit 3 includes a clutch 28 that is fixedly coupled to the knob 13 such that the clutch 28 and the knob 13 do not rotate or move axially relative to one another during setting of a drug dose and dispensing of the drug dose. The clutch 28 is coupled to the proximal drive sleeve 20 via a splined engagement. This splined engagement may allow some axial movement of the clutch 28 relative to the proximal drive sleeve 21, but does not allow relative rotation between these two elements.
[0107] The distal clicker 23, the proximal clicker 24, and the clutch spring 25 of the drive unit 3 are disposed between the clutch 28 and the drive sleeve coupler 22. The clutch spring 25 is coupled to the drive sleeve coupler 22 and the distal clicker 23. The distal clicker 23 is configured to urge the proximal clicker 24 in the proximal direction P. The proximal clicker 24 is configured to urge the clutch 28 in the proximal direction P. Thus, the clutch spring 25 is configured to urge the distal clicker 23, the proximal clicker 24, and the clutch 28 in the proximal direction P relative to the drive sleeve coupler 22.
[0108] The distal clicker 23 is permanently splined to the proximal drive sleeve 21 such that relative rotation between the distal clicker 23 and the proximal drive sleeve 21 is prevented, but some axial movement between the distal clicker 23 and the proximal drive sleeve 21 is permitted. The proximal clicker 24 is permanently splined to the inner body 10 such that relative rotation between the proximal clicker 24 and the inner body 10 is prevented, but some relative axial movement is permitted.
[0109] The distal surface of the clutch 28 and the proximal surface of the proximal clicker 24 are both toothed so that the two surfaces can engage with each other. Furthermore, the distal surface of the proximal clicker 24 and the proximal surface of the distal clicker 23 are both toothed so that the two toothed surfaces can engage with each other. The proximal surface of the clutch 28 may be toothed, e.g., dog-toothed, and is arranged to engage with the toothed, e.g., dog-toothed, distal surface of the dial sleeve 27.
[0110] FIG. 1 shows the drug delivery device 1 when no dose is set (0 units / 0 units position). Dose setting is possible in discrete units of 1, e.g. 0-80 units. To set the desired drug dose, the user must turn the knob 13. This is done without pushing the knob 13 in the distal direction D. Unless the knob 13 is pushed in the distal direction D, a dog-tooth engagement between the clutch 28 and the dial sleeve 27 is established by the clutch spring 25 biasing the clutch 28 in the proximal direction P, or at least preventing the clutch 28 from moving in the distal direction D on its own. The dog-tooth engagement between the clutch 28 and the dial sleeve 27 results in the two elements being non-rotatably locked relative to each other, such that when the knob 13 is turned, the dial sleeve 27 and the number sleeve 26 are also rotated. Because the dial sleeve 27 is threadably engaged to the inner body 10, rotating the knob 13 results in the knob 13, clutch 28, dial sleeve 27 and number sleeve 26 moving in a helical path in the proximal direction P relative to the bodies 10, 11, thereby increasing the number on the number sleeve 26 visible through the window 12.
[0111] The proximal drive sleeve 21 is splined to the clutch 28 so that the proximal drive sleeve 21 , and with it the distal drive sleeve 20 and drive sleeve coupler 22 , move in a helical path in the proximal direction P relative to the inner body 10 .
[0112] The plunger rod 29 includes two overlapping, opposing external threads that are in threaded engagement with the internal threads of the distal drive sleeve 20. The threads are selected such that the plunger rod 29 does not rotate or move axially during the spiral movement of the distal drive sleeve 20 in the proximal direction P.
[0113] The final dose nut 30 is splined to the inner body 10 and therefore cannot rotate relative to the inner body 10. Due to the threaded engagement of the final dose nut 30 with the distal drive sleeve 20, the final dose nut 30 is forced to move in the proximal direction P during setting of the drug dose. Once the maximum dose is set (e.g. 80 units - whether set in only one drug setting step or in multiple drug setting steps), the final dose nut 30 establishes a rotational lock interface with the distal drive sleeve 20 such that the final dose nut 30 can no longer rotate relative to the distal drive sleeve 20. As a result, the distal drive sleeve 20 can no longer rotate and no further drug doses can be set. The drug delivery device 1 must then be reset to its initial state.
[0114] During setting of the drug dose, the toothed faces of the opposing distal and proximal clickers 23, 24 ratchet over each other, thereby generating an audible click that indicates to the user that the drug dose has been set. For this purpose, the teeth of the two faces are preferably shaped as shallow triangles, allowing relative rotation between clickers 23, 24 and causing slight repeated compression and decompression of the clutch spring 25.
[0115] After the desired dose is set, the user can push the knob 13 in the distal direction D to dispense the set drug dose. This transfers the distal force on the knob 13 from the knob 13 through the clutch 28 to the proximal clicker 24 and from there to the distal clicker 23, which compresses the clutch spring 25. The two clickers 23 and 24 press against each other and their toothed surfaces engage. Relative rotation between the two clickers 23, 24 is then prevented. Since the proximal clicker 24 is splined to the inner body 10 and the distal clicker 23 is splined to the proximal drive sleeve 21, the proximal drive sleeve 21 can no longer rotate relative to the inner body 10. However, since the proximal drive sleeve 21 is also splined to the clutch 28, the clutch 28 and the knob 13 can no longer rotate relative to the inner body 10 either.
[0116] The distal force applied to the knob 13 results in the clutch 28 together with the knob 13 moving slightly in the distal direction D relative to the dial sleeve 27, so that the clutch spring 25 is compressed, as already mentioned. The engagement by the dog teeth between the dial sleeve 27 and the clutch 28 is thereby released so that the dial sleeve 27 is no longer locked against rotation relative to the clutch 28. Thus, when the knob 13 is pushed in the distal direction D, the dial sleeve 27 together with the number sleeve 26 can still rotate relative to the inner body 10. Now, when the knob 13 moves in the distal direction D, the stop for the dial sleeve 27 also forces the dial sleeve 27 to move in the distal direction D. Due to the threaded engagement between the dial sleeve 27 and the inner body 10, the dial sleeve 27 moves in a spiral path together with the number sleeve 26 in the distal direction D. The numbers of the number sleeve 26 visible in the window 12 are thereby reduced.
[0117] At the same time, the clutch 28, the clickers 23, 24 and the drive sleeves 20, 21, 22 are forced to move (without rotating) in the distal direction D. The threaded engagement between the plunger rod 29 and the distal drive sleeve 20 forces the plunger rod 29 to rotate. Then, further threaded engagement between the plunger rod 29 and the internal thread of the inner body 10 forces the plunger rod 29 to also move in the distal direction D to push the stopper 17 in the cartridge 16 in the distal direction D to dispense the set drug dose. Since the distal drive sleeve 20 does not rotate during dispensing, the final dose nut 30 moves in the distal direction D together with the distal drive sleeve 20 without changing its position relative to the distal drive sleeve 20.
[0118] After dispensing the set drug dose, when the knob 13 has returned completely to its initial position, a new drug dose is set by rotating the knob 13 again along a helical path in the proximal direction P. During this time the position of the plunger rod 29 remains unchanged. Only when dispensing a dose is the plunger rod 29 moved in the distal direction D.
[0119] As explained with respect to Figure 1, one user interface member in the form of knob 13 is used not only for setting the drug dose but also for dispensing the drug dose, however, it is also possible to use separate user interface members for setting and dispensing the drug dose.
[0120] Further examples of drive units 3 realised with the injection device 1 can be found in WO 2014 / 033195 A1 or WO 2014 / 033197 A1, the entire text of which is incorporated herein by reference.
[0121] The drive unit 3, and in particular the drive unit housing 9, comprises dedicated fastening structures 32, 34, as shown in Figure 5. Here, by way of example only, the fastening structures 32, 34 are provided by windows 12 projecting radially outwardly from the outer surface of the tubular drive unit housing 9.
[0122] In effect, the radially outwardly projecting windows 12 comprise window inserts assembled and arranged in the respective through openings of the tubular outer body 11. The fastening structure 32 comprises a first side edge and the opposite fastening structure 34 comprises a second side edge. The oppositely situated side edges of the window 12 serve as first and second fastening structures 32, 34 for engaging with corresponding fastening structures of complementary shape provided, for example, on the bottom of the housing 201 of the auxiliary device 200. The bottom of the housing 201 faces the outer surface of the drive unit housing 9 and is configured for mechanical engagement with the fastening structures 32, 34.
[0123] 5 , by way of example only, the auxiliary device 200 includes a first fastener 202 and a second fastener 204. The fasteners 202, 204 are realized as clip joints or as clip-type fasteners that enable and support a form-fit of the auxiliary device 200 to the drive unit housing 9.
[0124] The fasteners 202, 204 and fastening structures 32, 34 are configured to fasten and fix the auxiliary device 200 in a well-defined position or orientation relative to the drive unit housing 9. The drug delivery device 1 and the auxiliary device 200 form or constitute a drug delivery system 400, which in this embodiment is realized as a drug injection system.
[0125] As particularly shown in Figures 2-4, the drive unit 3 includes a movable drive unit part 40. In this embodiment, the drive unit part 40 is movable during dose setting as well as during dose dispensing. The drive unit part 40 is provided or configured by the number sleeve 26 as described above. The drive unit part 40 is rotated, e.g. helically rotated, relative to the inner body 10 during and / or for setting a drug dose. The drive unit 3 further includes a locking mechanism 50. The locking mechanism 50 includes a mechanical locking element 51. The locking element 51 is transitionable between a release position, shown in Figures 2 and 4, and a locked position, shown in cross section in Figure 3. When in the locked position, the mechanical locking element 51 is in an interlocking configuration with the movable drive unit part 40. Thus, when the mechanical locking element 51 is in the locked position, the mechanical locking element 51 functions to prevent and / or impede rotational movement and / or to prevent or impede longitudinal movement of the drive unit part 40 relative to the drive unit housing 9.
[0126] As can be further seen from Figures 2-4, the mechanical locking element 51 includes a latch 53 having a projection 55 that engages a complementary shaped toothed structure 43 on the outer surface 42 of the sidewall 41 of the tubular device unit component 40. The toothed structure 43 includes a circumferential row of radially projecting teeth 44 and recesses 45.
[0127] As shown in FIG. 3, in the locking configuration or blocking position, the latch 53, in particular the projection 55 extending radially of the latch 53, engages with the recess 45 located between two consecutive teeth 44 located in the circumferential direction of the toothed structure 43. In this position of the locking element 51, the device unit part 40 is non-rotatably locked to the locking element 51. The locking element 51 itself is pivoted inside the drive unit housing 9. The locking element 51 is pivotable about a pivot shaft 52, as shown in FIG. 2. The pivot shaft 52 may extend along a tangential direction or along a longitudinal direction with respect to the tubular shape of the drive unit housing 9. The pivot shaft 52, and thus the mechanical locking element 51, is fixed to the drive unit housing 9. The pivot shaft 52 is fixed to a window 12 or a window insert fixed to a side wall of the drive unit housing 9. In effect, the locking mechanism 50 having a locking element 51 comprises a pawl that mechanically engages with the toothed structure 43 of the device unit part 40 .
[0128] The locking element 51 can be moved to the released configuration shown in Figs. 2 and 4 only or exclusively by an electrically controlled release mechanism 250 of the auxiliary device 200. The auxiliary device 200 includes an electronic unit 270 featuring a printed circuit board 271, a processor 272, a battery 273, and an electromagnet 277, for example implemented as or including a solenoid. The electromagnet 277 forms or constitutes an electromechanical actuator 251. By applying an appropriate current to the electromagnet 277, the actuator 251 is appropriately actuated. The actuator 251, and thus the electromagnet 277, controlled by the processor 272, is operable to generate a magnetic field. The magnetic field is configured to magnetically interact with the body 58 of the locking element 51. The body 58, or at least a portion thereof, includes a ferromagnetic or magnetized material to magnetically interact with the magnetic field provided or generated by the electromechanical actuator 251 or the electromagnet 277. In this manner, a magnetic force can be applied to the mechanical locking element 51 which is operable to lift or disengage the latch 53 from the toothed structure 43 .
[0129] 4, when the mechanical locking element 51 is moved to the release configuration or position, the locking mechanism 50 is released, allowing and supporting the rotation of the device unit part 40 relative to the drive unit housing 9. Instead of a pivoting arrangement of the mechanical locking element 51, it is also conceivable that the mechanical locking element 51 is elastically deformable. Here, the elastically deformable member of the locking element 51 may comprise a ferromagnetic or magnetized material so as to magnetically interact with the magnetic field provided or generated by the electromagnet 277.
[0130] The elastically deformable locking element 51 is inherently provided with a respective return force that serves to move or transition the mechanical locking element 51 into a locked configuration or blocking position in the absence of a magnetic field. In the case where the locking element 51, and thus the locking mechanism 50, includes a pivotable latch 53, it is particularly beneficial to have a return spring 56 that urges or biases the mechanical locking element 51 towards the locked position, as shown in Figures 2 and 4. The mechanical locking element 251 then remains in locking engagement with the drive unit part 40 in the absence of any interaction with the electrically controlled release mechanism 250.
[0131] In effect, to unlock the locking mechanism 50, it is required that the auxiliary device 200 is suitably mounted on the drive unit housing 9 and generates a respective magnetic field operable to move the mechanical locking element 51 to the released position. Here, the auxiliary device 200, in particular its electronic unit 270, may be operable to control the activation of the actuator 251 to move the mechanical locking element 51 to the released or unlocked position.
[0132] 6 and 7 show a portion of the drive unit 3 near its distal end, which is configured to be releasably fastened to a container unit. These figures show the functional principle of a container locking mechanism 60 configured to prevent the container unit 2 from being decoupled or separated from the drive unit 3 when a drug dose has been set but not fully dispensed.
[0133] One of the inner body 10 and the outer body 11 includes an interface feature 66, for example in the form of an internal thread 67. The reservoir unit 2, in this case the reservoir holder 15 of the drug reservoir unit 2, includes an interface feature 68, for example in the form of an external thread 69. The two threads 67, 69 can engage, thereby establishing a coupling interface in the form of a thread-type interface, whereby the reservoir unit 2 is releasably coupled to the drive unit 3. To release the coupling and the coupling interface, the reservoir unit 2 may have to be rotated and moved in a distal direction P relative to the bodies 10, 11.
[0134] However, in Fig. 6 the locking mechanism 60 is in a locked state, thereby preventing the coupling interface from opening. The locking mechanism 60 comprises a coupling element 64 in a locked position engaging with the reservoir holder 15. The coupling element 64 comprises at its distal end a coupling feature in the form of a protrusion that engages with a coupling feature, i.e. a recess or groove, of the reservoir holder 15. This engagement prevents the reservoir unit 2 from moving axially and possibly also rotationally relative to the body 10, 11, thereby preventing the coupling interface from opening.
[0135] The coupling element 64 is pivotally suspended from the drive unit 3 via a joint connection 61 with the inner body 10. This joint connection 61 allows the coupling element 64 to be rotated from a locking position in Figure 6 to a release position shown in Figure 7.
[0136] The coupling element 64 is an elongate element having a main section extending essentially longitudinally and a further section 62 extending perpendicularly to the main section and to the axis of rotation about which the coupling element 64 can rotate. The coupling element 64 forms part of the locking mechanism 60 and is arranged such that the number sleeve 26, which moves longitudinally during dose setting and dose dispensing, can hit the coupling element 64, which is radially offset from the joint connection 61, when it reaches the first position (see FIG. 7), in order to apply a torque to the coupling element 64. This torque moves the coupling element 64 from the locked position to the released position of FIG. 7. This happens purely mechanically via the leverage effect.
[0137] As can be seen in Fig. 7, when the number sleeve 26 is in the first position and the coupling element 64 accordingly in the released position, the coupling element 64 is no longer engaged with the reservoir unit 2, allowing release of the coupling interface. This state of the locking mechanism 60 is referred to as the released state. The user can separate the reservoir unit 2 from the drive unit 3, for example to replace the reservoir unit 2 or the drug reservoir 16. If the number sleeve 26 is moved in the proximal direction P, for example during dose setting, the coupling element 64 automatically returns to its locking position and release of the coupling interface is again prevented.
[0138] 6 and 7 is particularly useful for preventing a user from replacing the reservoir unit 2 when a non-zero drug dose is currently set. As described above, setting a drug dose involves movement of the number sleeve 26 in the proximal direction P. The locking mechanism 60 is used in any of the exemplary embodiments of the drug delivery device described herein.
[0139] In Figures 9 to 11 another example of an injection device 101 is shown with an electronic unit 270 at its proximal end and with a reservoir unit 2. The device 101 of Figures 9 to 11 comprises a different type of drive unit 103 compared to the examples of Figures 1 to 7. This particular drive unit 103 is described in more detail, for example, in WO 2004 / 078239 A1, WO 2004 / 078240 A1 or WO 2004 / 078241 A1, the entire contents of which are incorporated herein by reference.
[0140] The drive unit 103 includes a number sleeve 180 configured to move when the dose dial 112 is turned to provide a visual indication of the currently set dose. The dose dial 112 rotates a helical path relative to the housing 109 as it is rotated during setting and / or dispensing or expelling a dose. The housing 109 may include a window 108, for example in the form of an aperture through which a portion of the outer surface of the number sleeve 180 is visible.
[0141] The injection device 101 is configured to generate a mechanical click sound when the dose dial 112 is turned, providing acoustic feedback to the user. The number sleeve 180 mechanically interacts with a stopper 117 in the cartridge or medicament container 116. During delivery of a dose, the dose dial 112 rotates with an axial movement, i.e. without rotation, to its initial position, while the number sleeve 180 rotates back to its initial position, e.g. to indicate a dose of zero units. The injection device 101 can be realized as a disposable injection device. The cartridge holder 115 is sized and configured to accommodate the medicament container 116. The cartridge holder 115 is non-removably fastened by its proximal end to the proximal housing part 109, realized for example as the body of the drive unit 103. The cartridge holder 115 is covered by a protective cap 114, which is removably fastened to the cartridge holder 115 and / or the housing 109.
[0142] The housing 109 and / or an internal flange-like support includes a threaded axial through-hole that threadably engages with a first or distal thread of the piston rod 120. The distal end of the piston rod 120 includes a bearing in which a presser 123 is free to rotate about the longitudinal axis of the piston rod 120. The presser 123 is configured to axially abut against a proximally facing thrust bearing surface of the stopper 117 of the container 116. During a dispensing operation, the piston rod 120 rotates relative to the housing 109, thereby imparting a distal forward movement relative to the housing.
[0143] The piston rod 120 comprises a first thread 122 at or near its distal end and further comprises a second thread 124 at its proximal end. The first thread 122 and the second thread 124 are on opposite sides. A drive sleeve 130 is further provided having a hollow interior for receiving the piston rod 120. The drive sleeve 130 comprises an internal thread for threadedly engaging the proximal thread of the piston rod 120. The drive sleeve 130 further comprises an externally threaded section 131 at its distal end. The threaded section 131 is axially constrained between a distal flange portion 132 and another flange portion 133, i.e. a proximal flange portion 133 located at a predefined axial distance from the distal flange portion 132. Between the two flange portions 132, 133 is provided a final dose limiter 135 in the form of a semicircular nut having an internal thread that fits into the threaded section 131 of the drive sleeve 130.
[0144] The final dose limiter 135 further includes a radial recess or protrusion on its outer periphery for engaging a complementary shaped recess or protrusion on the inside of the side wall of the housing 109. In this manner, the final dose limiter 135 is splined to the housing 109. During successive dose setting procedures, rotation of the drive sleeve 130 in the dose increment or clockwise direction results in a cumulative axial displacement of the final dose limiter 135 relative to the drive sleeve 130.
[0145] There is further provided an annular spring 136 which axially abuts a proximally facing surface of flange portion 133. There is further provided a tubular clutch 170. A first end of clutch 170 is provided with a series of circumferentially oriented sawtooths. A radially inwardly facing flange is disposed toward a second, opposite end of clutch 170.
[0146] Further, a dose dial sleeve, also indicated as number sleeve 180, is provided. The number sleeve 180 is provided outside the spring 136 and the clutch 170 and is located radially inside the housing 109. A helical groove 181 is provided around the outer surface of the number sleeve 180. The housing 109 is provided with a dose window through which a portion of the outer surface of the number sleeve 180 can be seen. The housing 109 further comprises a helical rib 111 on the inner sidewall portion of the insert piece 110, which is adapted to seat in the helical groove 181 of the number sleeve 180. The tubular insert piece 110 is inserted into the proximal end of the housing 109. The insert piece 110 is non-rotatably and axially fixed in the housing 109. A first and a second stop are provided in the housing 109 to limit the dose setting procedure while the number sleeve 180 rotates in a helical motion relative to the housing 109.
[0147] A dose dial 112 in the form of a dose dial grip is disposed about the outer surface of the proximal end of the number sleeve 180. The outer diameter of the dose dial 112 typically corresponds to, coincides with and may form or be part of the outer diameter of the housing 109. The dose dial 112 is non-rotatably fixed to the number sleeve 180 to prevent relative movement therebetween. The dose dial 112 includes a central opening.
[0148] The trigger 113, also indicated as dose button, is substantially T-shaped. The trigger 113 is provided at the proximal end of the injection device 1. The trigger 113 may form or constitute the proximal end of the housing 109. The shaft 119 of the trigger 113 extends through an opening in the dose dial 112, through the inner diameter of the extension of the drive sleeve 130, and into a receiving recess in the proximal end of the piston rod 120. The shaft 119 is held against limited axial movement within the drive sleeve 130 and against rotation relative to the drive sleeve 130. The head of the trigger 113 is generally circular. A trigger side wall or skirt extends from the periphery of the head and is further adapted to seat in a proximally accessible annular recess of the dose dial 112.
[0149] To dial in the dose, the user rotates the dose dial 112. With the spring 136 and clutch 170 engaged, the drive sleeve 130, spring 136, clutch 170 and number sleeve 180 rotate together with the dose dial 112. Torque is transferred through the sawtooth between the spring 136 and clutch 170. The helical groove 181 of the number sleeve 180 and the helical groove of the drive sleeve 130 have the same lead. This causes the number sleeve 180 to extend from the housing 109 and the drive sleeve 130 to lift the piston rod 120 at the same speed. At the limit of travel, the radial stop of the number sleeve 180 engages either the first stop or the second stop provided on the housing 109, preventing further movement in the first rotational sense, e.g. the dose increase direction. Rotation of the piston rod 120 is prevented by the fact that the entire driven thread on the piston rod 120 is in the opposite direction.
[0150] A final dose limiter 135 , which is keyed to the housing 109 , is advanced along the threaded section 131 by rotation of the drive sleeve 130 .
[0151] During dialing or setting of a dose, the ratchet mechanism permits and supports rotation of the number sleeve 180 relative to the clutch 170 along a second rotational sense, which rotation is accompanied by a regular click of the flexible arms of the clutch 170. Angular momentum applied to the number sleeve 180 along a first rotational sense is consistently transferred to the clutch 170, where the mutually corresponding ratchet configurations of the ratchet mechanism provide torque transfer from the number sleeve 180 to the clutch 170.
[0152] Once the desired dose has been dialed in, the user can dispense the set dose by simply depressing the trigger 113. This causes the clutch 170 to displace axially relative to the number sleeve 180, disengaging its dog teeth. However, the clutch 170 remains keyed for rotation relative to the drive sleeve 130. The number sleeve 180 and dose dial 112 are now free to rotate in accordance with the helical grooves 181.
[0153] The axial movement deforms the flexible arm of spring 136, ensuring that the sawtooth does not loosen during dispensing. This prevents drive sleeve 130 from rotating relative to housing 109, but is still free to move axially relative to housing 109. This deformation is then used to push spring 136 and clutch 170 back along drive sleeve 130, restoring the connection between clutch 170 and digit sleeve 180 when distally directed dosing pressure is removed from trigger 113.
[0154] Longitudinal axial movement of the drive sleeve 130 rotates the piston rod 120 through a through-hole in the support of the housing 109, thereby advancing the stop 17 in the container 16. Once the dialed dose has been dispensed, the number sleeve 180 is prevented from further rotation by contact of at least one stop extending from the dose dial 112 with at least one corresponding stop on the housing 109. The zero dose position is determined by one of the axially extending edges or stops of the number sleeve 180 abutting at least one or several corresponding stops on the housing 109.
[0155] In a further example of Figs. 9-11, the auxiliary device 300 is configured to attach to a dose dial 112 provided at the proximal end of the drug delivery device 101. As shown in Figs. 10 and 11, the auxiliary device 300 comprises a multi-part housing 301, where a first housing part 302 is configured to fasten to the dose dial 112. When the auxiliary device 300 is properly fastened by its fasteners 303, for example to a fastening structure 102 provided on the outer periphery of the dose dial 112, a friction fit with the outer surface of the dose dial 112 is formed. The release mechanism 350 of the auxiliary device 300 is then properly aligned with the bore 142 of the drive unit part 140.
[0156] The second housing part 304 is longitudinally movable relative to the first housing part 302. While the first housing part 302 remains fixed to the dose dial 112, the second housing part 304 mechanically engages a carrier 306 featuring at least one distally facing abutment or protrusion 308, whereby the carrier 306, and thus the second housing part 304, is configured to longitudinally abut an outwardly facing end surface 144 of the trigger 113, which is here realized as a drive unit part 140 movable relative to the drive unit housing 109 to dispense a drug dose.
[0157] Here, the drive unit 103 of the injection device 101 comprises a different kind of locking mechanism 150, which is integrated or realised inside a drive unit part 140, currently realised as a trigger 113 or a trigger button.
[0158] As shown in Figures 10 and 11, the locking mechanism 150 comprises a mechanical locking element 151 realized as a locking bolt 153 longitudinally movable in a bore 142 of the drive unit part 140. The drive unit part 140 comprises a radially widened flange portion 143 and a distally extending shaft characterized by a somewhat tubular side wall 141. The bore 142 forms or constitutes a cup-shaped receptacle opening towards the proximal direction P. At the bottom of the bore 142 is arranged a return spring 156 which longitudinally or axially engages with the distal end or distally facing abutment surface of the locking element 151.
[0159] The locking element 151 includes a body 158 having a cross-section or diameter that matches a corresponding cross-section or diameter of the bore 142. The size of the bore 142 is smaller than a fingertip. The size of the bore 142 is also smaller than a conventional pointed object such as a ballpoint pen. When the auxiliary device 300 is properly fastened by its fasteners 303 to the outer periphery of the dose dial 112, thus forming a friction fit with the outer surface of the dose dial 112, the release mechanism 350 of the auxiliary device 300 is properly aligned with the bore 142.
[0160] Here, the release mechanism 350 includes an electromechanically implemented actuator 351 including a pin 353 movable in a longitudinal direction A. The actuator 351 is operable and / or actuatable by the electronic unit 270. When the auxiliary device 300 is properly assembled to the dose dial 112 and thus to the proximal end of the drive unit housing 109, the pin 353 is longitudinally aligned with the bore 142. The cross section or diameter of the pin 353 is sized to enter the bore 142 and is further operable to exert a distally directed force on the locking element 151. An activated actuator 351, and thus the distally protruding pin 353, biases the locking element 151 in the distal direction D within the bore 142 against the action of the return spring 156. The movement of the pin 353 is controllable by the electronic unit 270, as will be further described below.
[0161] As further shown in Figures 10 and 11, the drive unit part 140 further comprises at least one or more retaining elements 155. In the currently illustrated example, the retaining elements 155 each have a spherical shape. The retaining elements 155 are located in a portion of the side wall 141 of the drive unit part 140. The retaining elements 155 are movable in a radial direction R from a retaining position shown in Figure 10 towards a release position shown in Figure 11. In the retaining position, the retaining elements 155 at least slightly protrude radially outward from the side wall 141 of the drive unit part 140. Furthermore, the retaining elements 155 are axially fixed to the side wall 141 or axially confined to the side wall 141.
[0162] The retaining element 155 axially or longitudinally engages with a respective surface or abutment of the drive sleeve 130, for example provided at the proximal end of the drive sleeve 130. The drive sleeve 130 functions as a further drive unit part longitudinally fixed to the drive unit housing 109 as long as the clutch 170 is engaged. Disengagement of the clutch 170 requires a distal depression or movement of the trigger 113 and thus the drive unit part 140.
[0163] Such distal movement is effectively prevented by the retaining element 155 as long as it is in longitudinal engagement or longitudinal abutment with the drive sleeve 130. To unlock the locking mechanism 150, it is necessary to push the locking element 151, and thus the locking bolt 153, in the distal direction D. As shown in FIG. 10, the locking bolt 153 includes a radial recess 154, which is aligned with the retaining element 155 when the locking element 151 reaches a release position relative to the drive unit part 140. The recess 154, for example realized as an annular shaped groove on the outer surface of the locking bolt 153, is sized to receive at least a part of the retaining element 155.
[0164] 11 , retaining element 155 can enter recess 154 and simultaneously disengage from drive sleeve 130. Radial inward movement of retaining element 155, which is possible due to the longitudinal alignment of retaining element 155 and recess 154, then causes retaining element 155 to disengage from drive sleeve 130 and thus no longer impede distal movement of drive unit component 140 relative to drive unit housing 109.
[0165] By deactivating the release mechanism 350 and thus retracting the pin 353 in the proximal direction D, the blocking elements 151 undergo a respective proximally directed sliding movement under the action of the return spring 156. The retaining elements 155 are then biased radially outwards due to the oblique shape of the radial recess 154 provided in the locking bolt 153.
[0166] FIG. 8 is a schematic block diagram of an auxiliary device 200, 300 attached to the drug delivery device 1, 101 and operable to deform or control the locking mechanism 50, 150 of the injection device.
[0167] The auxiliary device 200 comprises in particular a printed circuit board (PCB) 271. The PCB is provided with a processor 272. The processor 272 may be, for example, a microprocessor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), etc. The processor 272 is configured and operable to execute program code (e.g. software or firmware) stored in a storage 275. The storage 275 may include a program memory, and may for example use a main memory to store intermediate results. The storage 275 may also be used to store a logbook regarding the ejections / injections performed. The storage 275, and thus the program memory, may for example be a read-only memory (ROM), and the main memory may for example be a random access memory (RAM).
[0168] In some examples, the processor 272 interacts with an input in the form of one or more buttons or actuators, for example, that turn the auxiliary device 200, 300 on and off. A further button can be implemented as a communication button. This further button can be used to trigger the establishment of a communication link or data connection to the external electronic device 80, for example, implemented as a smartphone. Yet another button can be implemented as a confirmation or OK button. This button can be used to confirm information presented to the user of the auxiliary device 200, 300. The button can be any suitable form of user input transducer, such as, for example, a mechanical switch, a capacitive sensor, or another touch sensor.
[0169] The processor 272 can control a display 278 or display unit, currently embodied as a liquid crystal display (LCD). The optional display 278 is operable to display, for example, the current settings of the injection device 1, 101, or information regarding the next injection to be performed to a user of the auxiliary device 200, 300. The display 278 or display unit can also be embodied as a touch screen display, for example, to receive user input.
[0170] The processor 272 may further be operatively coupled to a sensor 274. The sensor 274 may be implemented as an optical sensor embodied as an optical character recognition (OCR) reader, which may capture an image of the window 12 or the dose display in which the currently selected dose is displayed (according to numbers printed on a sleeve 26 included in the injection device 1, which numbers are visible through the window 12 or the dose display). The OCR reader may further recognize characters (e.g. numbers) from the captured image and provide this information to the processor 272.
[0171] Alternatively, the sensor 274 of the auxiliary device 200 may simply be an optical sensor, such as a camera, for capturing an image and providing information about the captured image to the processor 272. The processor 272 may then be operable to perform OCR on the captured image.
[0172] The processor 272 may also control a light source, such as a light emitting diode, to illuminate the window 12 in which the currently selected dose is displayed. A diffuser, for example made from a piece of acrylic glass, may be used in front of the light source. Additionally, the light sensor 274 may include a lens (e.g., an aspheric lens) that provides a magnification (e.g., a magnification of greater than 3:1).
[0173] The sensor 274 may also be implemented as an acoustic sensor, which is configured to sense sounds generated by the injection device 1, 101. Such sounds may occur, for example, when a dose is dialed in by turning the dose dial 112 or dose button 13, and / or when a dose is ejected / injected by the dose button 13 or trigger 113, and / or when a prime shot is performed. These actions are mechanically similar, but nevertheless have different sounds (which may even be electronic sounds indicating these actions). Here, either the sensor 274 and / or the processor 272 may be configured to distinguish between these different sounds, for example, so that it can be safely recognized that an injection has been performed (and not just a prime shot).
[0174] The processor 272 may further control a signal generator 279, implemented for example as an acoustic signal generator configured to generate an acoustic signal that may be related, for example, to an operating state of the injection device 1, 101, for example, as feedback to the user. For example, an acoustic signal is emitted by the signal generator 279 as a reminder of the next dose to be injected or as a warning signal, for example in case of misuse. The acoustic signal generator may be embodied, for example, as a buzzer or a speaker. In addition to or instead of the acoustic signal generator 279, a tactile signal generator (not shown) may also be used to provide tactile feedback, for example by vibration.
[0175] The processor 272 further controls a communication interface 276, implemented for example as a radio unit or radio transceiver. The communication interface 276 is configured to transmit and / or receive information to and from another device in a wireless manner. Such transmission can be based on radio or optical transmission, for example. Typically, the communication interface 276 is implemented according to a commercially available wireless communication standard, such as Bluetooth, Wi-Fi, UWB, or NFC.
[0176] Alternatively, the communication interface 276 may include a wired unit configured to transmit and / or receive information to and from another device in a wired manner, for example via a cable or fiber connection. When data is transmitted, the units of the transmitted data (values) can be explicitly or implicitly defined. For example, for insulin doses, International Units (IU) are always used, otherwise the units used are explicitly transferred, for example in coded form.
[0177] The processor 272 may be operable to receive input from a pen detection switch (not shown), which is operable to detect whether the pen 1 or drug delivery is present, i.e., whether the auxiliary device 200 is properly coupled to the injection device 1, 101. A battery 273 provides power to the processor 272 and other components of the electronic unit 270.
[0178] Thus, the auxiliary device 200, 300 can determine information related to the status and / or use of the injection device 1, 101. This information can be displayed on the display 21 for use by a user of the device. This information is either processed by the auxiliary device 200, 300 itself or at least partly provided to an external electronic device 80 for further data processing.
[0179] Generally, information regarding the size of the dose currently set, dialed or dispensed is obtained by the sensor 274 and stored in the local storage 275. Data repeatedly captured or acquired during repeated and subsequent uses of the injection device 1, 101 may be stored in the storage 275. Such injection related data stored in the storage 275 may be synchronized, for example, by the communication interface 276 communicating with an external electronic device 80 and / or with an external database 92, for example hosted or provided by a healthcare provider.
[0180] Typically, the external electronic device 80 is realized as a smartphone, a smart watch, or a tablet computer. The external electronic device 80 may also include a wide area communication interface 88 for establishing a communication link with an external database 92 via a communication network 90. Typically, the external electronic device 80 is a mobile device or a wearable device. The external electronic device 80 includes a display 81 and / or a speaker 82 for interacting with a user.
[0181] The external electronic device 80 can be wirelessly paired with the electronic unit 70. When the pairing is successful, a respective confirmation is provided to the user, e.g. via a display 81 and / or via a speaker 82 of the external electronic device 80. When data or information is transferred between the electronic unit 70 and the external electronic device 80, a visual and / or audible confirmation is provided to the user, e.g. by the electronic unit 70 and / or by the external electronic device 80.
[0182] The processor 272 is configured to perform automatic relocking, for example, after the end of each dosing or injection procedure. Furthermore, based on the signal obtained from the sensor 274, the processor 272 is provided with information indicative of the remaining fill level of the medicament container 16. In this manner, when the sensor 274 provides a respective sensor signal that the medicament container 16 is substantially depleted or empty, the processor 272 can control and / or actuate the release mechanism 250, 350, and thus the actuator 251, 351, to transition the mechanical locking element 51, 151 to the locked position.
[0183] In a further example, the electrically controlled release mechanism 250, 350 of the auxiliary device 200, 300 is controlled by the processor 272 based on an authentication routine implemented by the auxiliary device 200, 300 and / or implemented by the external electronic device 80. This may be particularly applicable to reusable injection devices 1, 101 having a common drive unit 3, 103 but differentiated by the container unit 2 and / or by the medicament stored in the medicament container 16, 116.
[0184] Here, a particular container unit 2 with a medicament container 16, 116 is visually or electronically coded by a respective coding feature, implemented for example as a barcode, as a QR code or in the form of an electronically readable code, for example provided by an RFID chip. At least one of the auxiliary device 200, 300 and the external electronic device 80 may be operable to capture and / or read or extract the coding feature of the container unit 2. Based on the captured coding feature, the processor 272 may be operable to activate or deactivate the release mechanism 250, 350. In the unlikely event that an incorrect container unit 2 is paired and / or coupled with the drive unit 3, the coding feature captured and / or processed by the processor 272 cannot operate to activate the release mechanism 250, 350 for switching the mechanical locking element to the release position. The locking mechanism 50, 150 can then remain in the locking position or locking configuration. Misuse or unintended use of the drive unit 3, 103 is effectively prevented.
[0185] The electronic unit 270, in particular its processor 272, may be operable to activate the release mechanism 250, 350 only if a correct coding feature is detected. The evaluation of the correct coding feature is performed by the processor 272 and / or by a processor of the external electronic device 80. Here, approval of the authentication to release the lock of the locking mechanism 50, 150 is also performed by the external electronic device. [Explanation of symbols]
[0186] 1. Drug Delivery Devices 2 Container unit 3 Drive unit 4 Distal end 5 Proximal end 9 Drive unit housing 10 Inner body 11 Outer body 12. Windows 13 Dose button 14 Protective cap 15 Cartridge holder 16 Drug containers 17 Stopper 18 Syringe needle 20 Distal Drive Sleeve 21 Proximal Drive Sleeve 22 Drive sleeve coupler 23 Distal Clicker 24 Proximal Clicker 25 Clutch spring 26 Number Sleeve 27 Dial Sleeve 28 Clutch 29 Plunger rod 30 Final Dose Nut 32 Fastening structure 34 Fastening structure 40 Device unit parts 41 Side wall 42 External Surface 43 Toothed structure 44 teeth 45 Recess 50 Locking mechanism 51 Locking Elements 52 Pivot Axis 53 Latch 55 Protrusion 56 Return spring 58 Main unit 60 Container locking mechanism 61 Joint connection part Section 62 64 Joint Elements 66 Boundary Function 67 Thread 68 Boundary Function 69 Threads 80 External Electronic Devices 81 Display 82 Speaker 86 Communication Interface 88 Communication Interface 90 Network 92 Database 101 Drug delivery devices 102 Fastening structure 103 Drive unit 108 Window 109 Drive unit housing 110 Insert 111 Rib 112 Dose Dial 113 Trigger 114 Protective Cap 115 Cartridge holder 116 Drug container 117 Stopper 119 Shaft 120 Piston rod 121 Bearing part 122 1st thread 123 Hold 124 Second Thread 130 Drive sleeve 131 Threaded Section 132 Flange 133 Flange 135 Final Dose Limiter 136 Spring 140 Drive unit parts 141 Side wall 142 Boa 143 Flange part 144 End face 150 Locking mechanism 151 Locking Elements 153 Locking Bolt 154 Recess 155 Holding Element 156 Return spring 158 Main Body 170 Clutch 180 Number Sleeve 181 Groove 200 Auxiliary Devices 201 Housing 202 Fasteners 204 Fasteners 250 Release mechanism 251 Actuator 270 Electronic Unit 271 Printed Circuit Board 272 processors 273 Battery 274 Sensors 275 Storage 276 Communication Interface 277 Electromagnet 278 Display 279 Signal Generator 300 Auxiliary Devices 301 Housing 302 Housing part 303 Fasteners 304 Housing part 306 Career 308 Protrusion 350 Release mechanism 351 Actuator 353 Pin 400 Drug Delivery Systems
Claims
1. A drive unit (3; 103) of a drug delivery device (1; 101) configured for setting and dispensing a drug dose, the drive unit (3) comprising: a drive unit housing (9; 109) extending along a longitudinal axis (A); - a drive unit part (40; 140) movably arranged in or on the drive unit housing (9; 109) for at least one of setting a dose and dispensing a medicament dose; a locking mechanism (50; 150) including a mechanical locking element (51; 151) that is transitionable between a release position and a locking position and configured to mechanically engage the drive unit part (40; 140) when in the locking position to inhibit at least one of setting a dose and dispensing a medicament dose; Including, The drive unit, wherein the mechanical locking element (51; 151) is exclusively transferable from a locked position to a released position by interaction with an electronically controlled release mechanism (250; 350) of an auxiliary device (200, 300) configured to be mounted on the drive unit housing (9; 109).
2. 2. The drive unit (3; 103) according to claim 1, wherein the mechanical locking element (51; 151) is movably arranged in the drive unit housing (9; 109).
3. 3. The drive unit (3; 103) according to claim 2, wherein the mechanical locking element (51; 151) is hidden by the drive unit housing (9; 109).
4. Drive unit (3; 103) according to any one of the preceding claims, wherein the mechanical locking element (51; 151) is not mechanically accessible from outside the drive unit housing (9; 109).
5. A drive unit (3; 103) according to any one of the preceding claims, wherein the drive unit housing (9; 109) comprises a recess (154) or access opening aligned with the mechanical locking element (151).
6. The drive unit (3; 103) according to any one of claims 1 to 5, wherein the mechanical locking element (51; 151) comprises a body (58; 158) having at least one of a ferromagnetic material and a magnetized material to magnetically interact with the release mechanism (250; 350).
7. 7. The drive unit (3; 103) of claim 6, wherein the drive unit housing (9; 109) includes a fastening structure (32, 34; 102) configured to releasably engage with a complementary fastener (202, 204; 303) of the auxiliary device (200; 300), and when the fastening structure (32, 34; 102) is properly engaged with the complementary fastener (202, 204; 303) of the auxiliary device (200, 300), the mechanical locking element (51; 151) is aligned with an actuator (251, 351) of the release mechanism (250; 350).
8. A drive unit (3; 103) according to any one of claims 1 to 7, wherein the mechanical locking element (51; 151) is movably fastened to one of the drive unit part (40; 140) and the drive unit housing (9; 109), and the mechanical locking element (51; 151) is configured to engage with the other of the drive unit part (40; 140) and the drive unit housing (9; 109) when transferred from a release position to a locking position.
9. A drive unit (3; 103) according to any one of claims 1 to 8, wherein the drive unit part (40) is rotatable about the longitudinal axis (A) for at least one of setting a dose and dispensing a dose, the drive unit part (40) comprises a tubular side wall (41) having a toothed structure (43), and the mechanical locking element (51) comprises a latch (53) which is radially movable, pivotable or deformable to engage with the toothed structure (43).
10. A drive unit (3; 103) according to any one of claims 1 to 9, wherein the drive unit part (140) is longitudinally displaceable for at least one of setting a dose and dispensing a dose, and the locking mechanism (150) comprises a holding element (155) which is longitudinally fixed to the drive unit part (140) with respect to the longitudinal axis (A) and radially movable with respect to the longitudinal axis (A) between a holding position and a release position.
11. A drive unit (3; 103) as claimed in claim 10, wherein the mechanical locking element (151) is movably supported in or on the drive unit part (140) and is mechanically engaged with the retaining element (155), and longitudinal movement of the mechanical locking element (151) from the locking position to the release position is effective to cause movement of the retaining element (155) from the retaining position to the release position.
12. A drive unit (3; 103) according to any one of claims 1 to 11, wherein the drive unit part (40; 140) is movable from an initial position to an end position for at least one of setting a dose and dispensing a dose, and when in the locking position, the mechanical locking element (51; 151) is operable to fix the drive unit part (40; 140) in the initial position.
13. A drive unit (3; 103) according to any one of claims 1 to 12, wherein the locking mechanism (50; 250) comprises a return spring (56; 256) operable to engage the mechanical locking element (51; 251) and transition the mechanical locking element (51; 251) from the released position to the locked position.
14. A drug delivery device (1) for setting and dispensing a drug dose, comprising: A drive unit (3; 103) according to any one of claims 1 to 13, The drug delivery device includes a container unit (2) configured to accommodate a drug container (16) and further configured to fasten to a drive unit housing (9; 109), the drive unit (3; 103) being configured to operatively engage with the drug container (16) to draw or expel a dose of drug from the drug container (16).
15. An auxiliary device (200; 300) for use with a drive unit (3; 103) according to any one of the preceding claims, comprising: a housing (201; 301) adapted to be mounted on a drive unit (3; 103); an electronic unit (270) disposed within the housing (201; 301); a release mechanism (250; 350) electrically controlled by an electronic unit (270) and including an electromagnetic actuator (251, 351) operable to move a mechanical locking element (51; 151) of a locking mechanism (50; 150) of the drive unit (3; 103) to a release position; The auxiliary device.
16. The electromagnetic actuator (251; 351) comprises: an electromagnet (277) operable to magnetically interact with the mechanical locking element (51; 151); and A movable pin (353) that mechanically engages with the mechanical locking element (151) 16. An auxiliary device (200; 300) according to claim 15, comprising at least one of:
17. A drug delivery system (400) comprising an auxiliary device according to claim 15 or 16 and further comprising a drive unit (3; 103) according to any one of claims 1 to 13.
Citation Information
Patent Citations
Drug injection device with lockout function
JP2013507159A
Mechanism to prevent dose selection
JP2013533075A
monitoring unit
JP2018527992A
